PROMETHERA BIOSCIENCES
Voor PROMETHERA BIOSCIENCES is een faillissementsprocedure geopend volgens publicaties in het Belgisch Staatsblad. Daarnaast bevat het dossier 4 gerechtelijke reorganisaties. De jaarrekening over 2022 toont een negatief eigen vermogen (€-1,50M) en een nettoresultaat van €-520k.
| Eigen vermogen | €-1,50M |
| Netto resultaat | €-520k |
| Beter dan sector | 5% |
| Actief | 17 jaar |
Kwetsbaar profiel, let vooral op gezondheid.
Faillissement geopend
Er loopt al een faillissementsprocedure, een kans-score is dan niet meer zinvol. Bekijk de insolventietijdlijn voor de stand van de procedure.
De volledige opbouw van de score, de scoregeschiedenis per boekjaar en de indicatieve kredietlimiet ontgrendel je met Plus.
Bekijk plannen →| Kengetal | Dit bedrijf | Sectormediaan | Positie in de sector |
|---|---|---|---|
| Solvabiliteit | -34,5% | 51,3% | |
| Nettoresultaat | €-520k | €40k | |
| Eigen vermogen | €-1,50M | €98k | |
| Bruto bedrijfsmarge | €55k | €110k | |
| Personeelskosten | €-1k | €220k |
| Boekjaar | 2022 |
|---|---|
| Omzet | - |
| EBITDA | - |
| Nettoresultaat | €-520k |
| Cashflow | - |
| Personeelskosten | €-1k |
| Belastingen op het resultaat | - |
| Dividenden | - |
| Totaal activa | €4,34M |
| Eigen vermogen | €-1,50M |
| Schulden | €5,84M |
| waarvan ≤ 1 jaar | €2,44M |
| waarvan > 1 jaar | €3,39M |
| Werkkapitaal | €1,83M |
| Werknemers (VTE) | - |
| 2022 | |
|---|---|
| Current ratio | 1,75 |
| Quick ratio | 1,75 |
| Werkkapitaalratio | 42,3% |
| Solvabiliteit | -34,5% |
| Debt / equity | -3,90 |
| Langetermijnschuldgraad | -2,27 |
| Interest coverage | - |
| Bruto rentabiliteit | - |
| Netto rentabiliteit | - |
| ROA | -12,0% |
| ROE | 34,7% |
| EBITDA-marge | - |
| Klantenkrediet (DSO) | - |
| Leverancierskrediet (DPO) | - |
| Voorraadrotatie | - |
| Voorraaddagen (DSI) | - |
| Post | Code | 2022 |
|---|---|---|
| Balans, Activa | ||
| TOTAAL ACTIVA | 20/58 | €4,34M |
| Vaste activa | 21/28 | €64k |
| Financiële vaste activa | 28 | €64k |
| Vlottende activa | 29/58 | €4,28M |
| Vorderingen op ten hoogste één jaar | 40/41 | €4k |
| Liquide middelen | 54/58 | €611 |
| Balans, Passiva | ||
| TOTAAL PASSIVA | 10/49 | €4,34M |
| Eigen vermogen | 10/15 | €-1,50M |
| Inbreng / kapitaal | 10/11 | €61,71M |
| Reserves | 13 | €17,09M |
| Overgedragen winst (verlies) | 14 | €-80,29M |
| Schulden | 17/49 | €5,84M |
| Schulden op meer dan één jaar | 17 | €3,39M |
| Schulden op ten hoogste één jaar | 42/48 | €2,44M |
| Handelsschulden op ten hoogste één jaar | 44 | €1,58M |
| Resultatenrekening | ||
| Bruto bedrijfsmarge | 9900 | €55k |
| Bedrijfsresultaat | 9901 | €-500k |
| Financiële kosten | 65 | €20k |
| Resultaat vóór belasting | 9903 | €-520k |
| Resultaat van het boekjaar | 9904 | €-520k |
| Te bestemmen resultaat | 9905 | €-455k |
| Rol | Naam | Periode | Bron |
|---|---|---|---|
| Curator | RODOLPHE DE SAN RUE DE CLAIRVAUX 40,
1348 LOUVAIN-LA-NEUVE |
27-05-2024 → heden | Belgisch Staatsblad |
| NACE primair | Gezondheidszorg(86995) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 12-02-2009 |
| Status | Actief |
| Postcode | 1435 |
| Eerste BS-signaal | 18-12-2020 |
| Laatste BS-signaal | 31-05-2024 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 25020B0074/00B002 | Wallonië | 6,2 ha | 1 · 17 m² | 7,8 m · 2 verd. |
| 52028B0323/00M003 | Wallonië | 8.679 m² | 1 · 791 m² | 18,8 m · 5 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
11-05-2022 1 bestuurder benoemd, 3 ontslagnemend
- Bruno De Keersmaeker, Bestuurder
- Eric Fok, Bestuurder
- Alain Parthoens, Bestuurder
- Reiko Namikawa, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Eric Fok",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Alain Parthoens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Reiko Namikawa",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Administrateur",
"person": {
"rrn": null,
"name": "Bruno De Keersmaeker",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}23-02-2022 1 bestuurder benoemd, 1 ontslagnemend
- Didier Delanoye, Commissaire
- Zimeng Dong, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Didier Delanoye",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Zimeng Dong",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}09-02-2022 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": "completed",
"notary": {
"name": "Kim Lagae",
"firm_city": null,
"firm_name": null,
"office_city": "Bruxelles",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": "2022-01-28",
"act_kind_objet": "CESSION DE BRANCHE D\u0027ACTIVITES"
},
"decision": {
"body": "notarieel_alleen",
"act_date": "2022-01-17",
"unanimous": null
},
"conversion": null,
"detected_kind": "branch_contribution",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0809.788.365",
"name": "PROMETHERA BIOSCIENCES",
"role": "contributor",
"address": "1435 Mont-Saint-Guibert, Watson \u0026 Crick Hill, rue Granbonpr\u00E9, 11",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0764.522.425",
"name": "Promethera Therapeutics",
"role": "recipient",
"address": "1435 Mont-Saint-Guibert, Watson \u0026 Crick Hill, rue Granbonpr\u00E9, 11",
"is_foreign": false,
"legal_form": "soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:103",
"12:93",
"12:94",
"12:95",
"12:97",
"12:98",
"12:99",
"12:100"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2021-02-23",
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "La cession concerne une branche d\u0027activit\u00E9 au sens de l\u0027article 12:11 du Code des soci\u00E9t\u00E9s et des associations, comprenant l\u0027ensemble des actifs (y compris les cr\u00E9ances), passifs, droits et obligations aff\u00E9rents aux \u00E9l\u00E9ments d\u00E9crits \u00E0 l\u0027annexe 1 du Projet Commun de Cession. Cette branche est technique et organisationnellement autonome, et peut fonctionner de mani\u00E8re ind\u00E9pendante.",
"equity_transferred_eur": null,
"accounting_effective_date": "2021-03-30"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES",
"legal_form": "soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Kim Lagae",
"org_rep_person_name": null
},
"summary_narrative": "La soci\u00E9t\u00E9 anonyme PROMETHERA BIOSCIENCES a c\u00E9d\u00E9 \u00E0 titre on\u00E9reux, \u00E0 la soci\u00E9t\u00E9 anonyme Promethera Therapeutics, une branche d\u0027activit\u00E9 constitu\u00E9e d\u0027actifs, passifs, droits et obligations li\u00E9s \u00E0 une activit\u00E9 autonome, conform\u00E9ment aux dispositions de l\u0027article 12:103 du Code des soci\u00E9t\u00E9s et des associations. Le transfert a \u00E9t\u00E9 effectu\u00E9 \u00E0 compter du 30 mars 2021, et les op\u00E9rations relatives \u00E0 cette branche sont comptabilis\u00E9es comme si elles avaient \u00E9t\u00E9 r\u00E9alis\u00E9es par la soci\u00E9t\u00E9 b\u00E9n\u00E9ficiaire.",
"co_filed_documents": [
"une exp\u00E9dition de l\u0027acte"
],
"detected_real_type": "branch_contribution",
"referenced_correction": null,
"should_reroute_to_category": null
}10-11-2020 5 bestuurders benoemd, 2 ontslagnemend
- Etienne Sokal, Dagelijks bestuur
- A Q Invest SRL, Dagelijks bestuur
- Alain Parthoens, Dagelijks bestuur
- Alick Dong, Dagelijks bestuur
- Etienne Sokal, Président du conseil d'administration
- Silver Ocean Ventures SAS, Administrateur, administrateur délégué
- Charles Dimmler, Administrateur, président du conseil d'administration
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur, administrateur d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Silver Ocean Ventures SAS",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Etienne Sokal",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "A Q Invest SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Alain Parthoens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Alick Dong",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur, pr\u00E9sident du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "Charles Dimmler",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "pr\u00E9sident du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "Etienne Sokal",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}25-09-2020 3 bestuurders benoemd
- Zimeng Dong, Bestuurder
- Chi Tak Fok, Bestuurder
- A Q Invest SRL, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Zimeng Dong",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Chi Tak Fok",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "A Q Invest SRL",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}02-09-2020 Masaki Doi neemt ontslag als administrateur indépendant
- Masaki Doi, Administrateur indépendant
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur ind\u00E9pendant",
"person": {
"rrn": null,
"name": "Masaki Doi",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}22-06-2020 1 bestuurder benoemd, 1 ontslagnemend
- Shintaro Hayashi, Bestuurder
- Tajio Enoki, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Tajio Enoki",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Shintaro Hayashi",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}11-02-2020 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
},
"legal_form_change": {
"new": "",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}09-01-2020 Kapitaalverhoging van €3.318.312,22 tot €20.318.312,22
- €17.000.000 → €20.318.312,22
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 20318312.22,
"delta_eur": 3318312.219999999,
"before_eur": 17000000.0,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}30-12-2019 Kapitaalverhoging van €338.246,60 tot €19.977.982,14
- €19.639.735,54 → €19.977.982,14
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19977982.14,
"delta_eur": 338246.6000000015,
"before_eur": 19639735.54,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}27-12-2019 Wijziging in het bestuur
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}18-11-2019 Kapitaalverhoging van €135.112,50 tot €19.639.735,54
- €19.504.623,04 → €19.639.735,54
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19639735.54,
"delta_eur": 135112.5,
"before_eur": 19504623.04,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}27-09-2019 Verrichting in kapitaal of aandelen
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}27-05-2019 Kapitaalverhoging van €11.311.354,92 tot €19.449.363,08
- €8.138.008,16 → €19.449.363,08
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 19449363.08,
"delta_eur": 11311354.919999998,
"before_eur": 8138008.16,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}02-04-2019 1 bestuurder benoemd, 1 ontslagnemend
- Tetsuya Kurihara, Bestuurder
- Kinji Fuchikami, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Kinji Fuchikami",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Tetsuya Kurihara",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}19-02-2019 Tajio Enoki benoemd tot bestuurder
- Tajio Enoki, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Tajio Enoki",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}10-01-2019 Kapitaalverhoging van €54.281,25 tot €10.760.883,85
- €10.706.602,60 → €10.760.883,85
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10760883.85,
"delta_eur": 54281.25,
"before_eur": 10706602.6,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}07-12-2018 Wijziging in het bestuur
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}30-11-2018 BDO ATRIO Réviseurs d'entreprises benoemd tot auditor
- BDO ATRIO Réviseurs d'entreprises, Auditor
Technische details
{
"events": [
{
"kind": "director_in",
"role": "auditor",
"person": {
"rrn": null,
"name": "BDO ATRIO R\u00E9viseurs d\u0027entreprises",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "Promethera Biosciences"
}
}23-08-2018 Kapitaalverhoging van €52.687,50 tot €10.706.602,60
- €10.653.915,10 → €10.706.602,60
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10706602.6,
"delta_eur": 52687.5,
"before_eur": 10653915.1,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}18-07-2018 Verrichting in kapitaal of aandelen
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}08-06-2018 Kapitaalverhoging van €1.153,53 tot €10.653.915,10
- €10.652.761,57 → €10.653.915,10
- Inbreng in natura · Apport en nature
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10653915.1,
"delta_eur": 1153.5299999993294,
"before_eur": 10652761.57,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}11-05-2018 Kapitaalverhoging van €1.033.579,39 tot €10.652.761,57
- €9.619.182,18 → €10.652.761,57
- Inbreng in natura · Apport en nature
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 10652761.57,
"delta_eur": 1033579.3900000006,
"before_eur": 9619182.18,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}03-05-2018 Kapitaalverhoging van €8.735.000 tot €9.619.182,18
- €884.182,18 → €9.619.182,18
- Inbreng in natura · Apport en nature
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 9619182.18,
"delta_eur": 8735000.0,
"before_eur": 884182.18,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}16-03-2018 3 bestuurders benoemd, 3 ontslagnemend
- Madame Reiko Namikawa, Bestuurder
- Monsieur Charles L. Dimmier III, Bestuurder
- Monsieur Masaki Doi, Bestuurder
- Sparaxis SA, Bestuurder
- Madame Ilka Wicke, Bestuurder
- Monsieur Jean-Paul Prieels, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Sparaxis SA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Madame Ilka Wicke",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur Jean-Paul Prieels",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Madame Reiko Namikawa",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur Charles L. Dimmier III",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Monsieur Masaki Doi",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}12-10-2017 Verrichting in kapitaal of aandelen
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}01-09-2017 Verrichting in kapitaal of aandelen
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}21-06-2017 Kapitaalverhoging van €112.162,50 tot €8.841.873,44
- €8.729.710,94 → €8.841.873,44
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8841873.44,
"delta_eur": 112162.5,
"before_eur": 8729710.94,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}04-01-2017 Kapitaalverhoging van €0,01 tot €8.729.710,94
- €8.729.710,93 → €8.729.710,94
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8729710.94,
"delta_eur": 0.009999999776482582,
"before_eur": 8729710.93,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}25-11-2016 Kapitaalverhoging van €990,99 tot €8.730.701,92
- €8.729.710,93 → €8.730.701,92
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 8730701.92,
"delta_eur": 990.9900000002235,
"before_eur": 8729710.93,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0809.788.365",
"name_full": "PROMETHERA BIOSCIENCES"
}
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | PROMETHERA BIOSCIENCES |